Search Browse Earnings

LUMOS PHARMA, INC.

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Hawkins Richard J

Revenue

$1.5M

+290.5% YoY

FY 2023

Adj. EBITDA

-$32.0M

-2100.5% margin

FY 2023

Net Income

-$31.1M

-2039.5% margin

FY 2023

EPS (Diluted)

-$3.71

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$56.0M

FY 2023

Total Debt

$6.0M

FY 2019

Net Cash

$50.0M

FY 2019

Enterprise Value

—

Debt / EBITDA

1.6x

FY 2023

EV / EBITDA

—

Employees

—